With effective systemic therapy and comprehensive supportive care, patients with metastases can live longer. Breast cancer patients with only or predominantly bone metastases have a median survival of 2.3 years following diagnosis, while metastatic prostate cancer patients have a median survival time of 11.3 months. With recent advances in research, the overall survivorship of metastatic patients has increased. The improved quality of care for metastatic cancer patients has resulted in longer survivorship. Living longer can lead to a higher chance of development for skeletal-related events (SREs), which are defined as either spinal cord compression, hypercalcemia, pathological fractures or a need for palliative radiation therapy or surgery for bone pain. To try to reduce pathological fractures, it is important to detect impending fractures earlier and to administer prophylactic surgery as needed. Longer survivorship also allows time for the development of brain metastases. Recent advances incorporating stereotactic radiosurgery (SRS) have been favored over conventional whole-brain radiation therapy (WBRT) in the preservation of neurocognitive functions and survival benefit in patients less than 50 years of age. Multidisciplinary clinics for brain metastases are again desirable with the joint input of the radiation oncologists and neurosurgeons.
"synopsis" may belong to another edition of this title.
Breanne Lechner, MD(C) is a clinical research assistant in the Rapid Response Radiotherapy Program at the Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada and also a medical student at the University of Toronto. She was the recipient of the J Frank Brookfield Scholarship from the University of Waterloo in 2012 for excellence in biology.
"About this title" may belong to another edition of this title.
Seller: UK BOOKS STORE, London, LONDO, United Kingdom
Condition: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. Seller Inventory # CVS 9781634839495
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 24905955-n
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GZ-9781634839495
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GZ-9781634839495
Quantity: 1 available
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 24905955-n
Quantity: 2 available
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. Editor(s): Lechner, Breanne; Chow, Ronald; Pulenzas, Natalie; Popovic, Marko B.; Zhang, Nan; Zhang, Xiaojing; Chow, Edward; Merrick, Professor Joav, MD, MMedSci, DMSc. Num Pages: 121 pages. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 230 x 155. . . 2015. 1st Edition. Hardcover. . . . . Seller Inventory # V9781634839495
Seller: Gazelle Books, Lancaster, LANCA, United Kingdom
Hardback. Condition: New. New Book, Direct from Publisher. Seller Inventory # 9781634839495
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. KlappentextrnrnWith effective systemic therapy and comprehensive supportive care, patients with metastases can live longer. Breast cancer patients with only or predominantly bone metastases have a median survival of 2.3 years following diagnosis. Seller Inventory # 118102676
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. Editor(s): Lechner, Breanne; Chow, Ronald; Pulenzas, Natalie; Popovic, Marko B.; Zhang, Nan; Zhang, Xiaojing; Chow, Edward; Merrick, Professor Joav, MD, MMedSci, DMSc. Num Pages: 121 pages. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 230 x 155. . . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Seller Inventory # V9781634839495
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - With effective systemic therapy and comprehensive supportive care, patients with metastases can live longer. Breast cancer patients with only or predominantly bone metastases have a median survival of 2.3 years following diagnosis, while metastatic prostate cancer patients have a median survival time of 11.3 months. With recent advances in research, the overall survivorship of metastatic patients has increased. The improved quality of care for metastatic cancer patients has resulted in longer survivorship. Living longer can lead to a higher chance of development for skeletal-related events (SREs), which are defined as either spinal cord compression, hypercalcemia, pathological fractures or a need for palliative radiation therapy or surgery for bone pain. To try to reduce pathological fractures, it is important to detect impending fractures earlier and to administer prophylactic surgery as needed. Longer survivorship also allows time for the development of brain metastases. Recent advances incorporating stereotactic radiosurgery (SRS) have been favored over conventional whole-brain radiation therapy (WBRT) in the preservation of neurocognitive functions and survival benefit in patients less than 50 years of age. Multidisciplinary clinics for brain metastases are again desirable with the joint input of the radiation oncologists and neurosurgeons. Seller Inventory # 9781634839495